Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
about
Pyruvate dehydrogenase kinase as a novel therapeutic target in oncologyPI3K/AKT/mTOR Pathway in AngiogenesisLactate activates HIF-1 in oxidative but not in Warburg-phenotype human tumor cellsHomeostatic modulation of cell surface KDR and Flt1 expression and expression of the vascular endothelial cell growth factor (VEGF) receptor mRNAs by VEGFRegulation of angiogenesis and tumor growth by p110 alpha and AKT1 via VEGF expressionPhosphatidylinositol-3-Kinase/Akt regulates bleomycin-induced fibroblast proliferation and collagen productionE2F7 and E2F8 promote angiogenesis through transcriptional activation of VEGFA in cooperation with HIF1The unfolded protein response induces the angiogenic switch in human tumor cells through the PERK/ATF4 pathwayMammalian tumor suppressor Int6 specifically targets hypoxia inducible factor 2 alpha for degradation by hypoxia- and pVHL-independent regulationVascular endothelial growth factor can signal through platelet-derived growth factor receptorsHypoxic conditions stimulate the production of angiogenin and vascular endothelial growth factor by human renal proximal tubular epithelial cells in cultureHypoxia up-regulated angiogenin and down-regulated vascular cell adhesion molecule-1 expression and secretion in human placental trophoblastsEAF2 suppresses hypoxia-induced factor 1α transcriptional activity by disrupting its interaction with coactivator CBP/p300Identification of the hypoxia-inducible factor 1 alpha-responsive HGTD-P gene as a mediator in the mitochondrial apoptotic pathwayMolecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300.Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alphamAKAP compartmentalizes oxygen-dependent control of HIF-1alphaChordin-like 1, a bone morphogenetic protein-4 antagonist, is upregulated by hypoxia in human retinal pericytes and plays a role in regulating angiogenesisCCI-779 inhibits rhabdomyosarcoma xenograft growth by an antiangiogenic mechanism linked to the targeting of mTOR/Hif-1alpha/VEGF signalingA novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular developmentHypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1Expression profiling of cytokines and related genes in regenerating skeletal muscle after cardiotoxin injection: a role for osteopontinVanadate-induced expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor through phosphatidylinositol 3-kinase/Akt pathway and reactive oxygen speciesMolecular responses to hypoxia in tumor cellsThe prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapyInfluence of hypoxia and neoangiogenesis on the growth of pancreatic cancerBreast cancer-induced angiogenesis: multiple mechanisms and the role of the microenvironmentUpregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritisExpression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breastTranscriptional repression of human cad gene by hypoxia inducible factor-1alphaSignaling Interplay between Bone Marrow Adipose Tissue and Multiple Myeloma cellsRole of hypoxia and vascular endothelial growth factors in lymphangiogenesisSirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular EffectsFucoidan as a Potential Therapeutic for Major Blinding Diseases--A HypothesisThe Role of miR-378a in Metabolism, Angiogenesis, and Muscle BiologyA Review of the Mechanisms of Blood-Brain Barrier Permeability by Tissue-Type Plasminogen Activator Treatment for Cerebral IschemiaEndothelial Transdifferentiation of Tumor Cells Triggered by the Twist1-Jagged1-KLF4 Axis: Relationship between Cancer Stemness and AngiogenesisOxidative Stress in Placenta: Health and DiseasesExploring the HIFs, buts and maybes of hypoxia signalling in disease: lessons from zebrafish modelsInhibition of Immune Checkpoints and Vascular Endothelial Growth Factor as Combination Therapy for Metastatic Melanoma: An Overview of Rationale, Preclinical Evidence, and Initial Clinical Data
P2860
Q21129303-D3785074-DE5D-4B54-8493-8C454F680276Q21129332-8F79F517-6682-4100-81BC-87806469C3BCQ21133953-3AEADDF0-0F53-40B4-9E63-D25332D0553EQ22253478-3956A406-F6A2-4B1A-BD37-BB23B5BC5059Q23910931-450DD20A-BBB5-4229-AA44-CF86F33AB12DQ23924071-521ACE5D-47FB-42DD-AFA3-A6CF6A48CCCDQ24296966-A4EC8D05-8FE6-48A3-9E54-4CF6B1024EB8Q24297372-31AB3406-FFAF-45B6-87F2-D90324323D60Q24298432-C2F19431-59C2-422A-8060-AAB771C6764BQ24304294-108B343C-9B74-4650-AB95-7C72DED6FF9CQ24305206-846FC102-346B-4BB8-A9C1-94E19472939CQ24306183-DB3910E4-E0F5-48FE-B16E-8E5A06BAEAA7Q24319939-CB742825-E672-43C1-8793-5ACB39576102Q24336803-99A53BB7-AC4D-4F96-8148-BBA37F6CDF4DQ24534053-C5E3D78B-AB10-44C7-9376-7CCE40AE5454Q24610199-9F096196-6A0A-4C38-AD8D-EF2B48E4C507Q24642510-535EBAB8-3800-4F4C-843C-D06044ED7A97Q24652148-2A39805B-04C2-4B7C-854E-F6D8CDDD259BQ24672058-9B15322A-7A8D-405F-9CE2-1DD042CEDDCBQ24681396-8A044195-4DDB-4E2B-8683-07EE7DC168B3Q24681460-83C42B6B-6D55-4143-8C94-34B91CDCCE74Q24685614-F4B7CB15-F992-4C0A-9201-3EB5FB7C7C86Q24720804-FC331640-D72B-441F-B327-DAB6CFD321FFQ24797310-670515FF-4C94-4360-B18E-FDEA5948B72AQ24801373-F500F185-95B7-4BDC-B1B8-FC368A290E3CQ24801511-456C89C1-B862-4B3E-9EC7-C94AEFBD8F36Q24803543-E1F73541-570D-46E0-9BB4-842A192D8DB2Q24804703-ED09AC3F-F333-4ECB-A840-51D9BE8DA6E4Q24813750-DCAE05D3-48E0-4669-923A-F323B57624A6Q24814445-0235F65E-9DAF-42EC-97CF-A5186E36ADF3Q26744596-0720002F-DA73-4C9B-9D04-1215B260D08FQ26745683-302AD394-38D8-4F6D-B328-9DDE78C0EAE2Q26749011-D79C85CC-502F-4146-8C68-E4341BC9F32BQ26768638-151566D4-9F2A-4B73-8125-E5D1D67DEB54Q26770132-B0B28FEB-F9F1-4611-881B-F55FEE967117Q26772837-688B9A6F-1ACE-4166-94C2-376B9C678718Q26773015-E88BEED9-277E-47FD-BF33-B09F5D6457CFQ26773521-B674CC01-6976-458B-B51C-21F4035606C2Q26778116-240C506C-6010-4006-BD0E-8129FA53A3D4Q26781098-0CC53A5D-B2FE-45B0-8008-360D7CB8DAD9
P2860
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
description
1996 nî lūn-bûn
@nan
1996 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Activation of vascular endothe ...... by hypoxia-inducible factor 1
@ast
Activation of vascular endothe ...... by hypoxia-inducible factor 1
@en
Activation of vascular endothe ...... by hypoxia-inducible factor 1
@en-gb
Activation of vascular endothe ...... by hypoxia-inducible factor 1
@nl
type
label
Activation of vascular endothe ...... by hypoxia-inducible factor 1
@ast
Activation of vascular endothe ...... by hypoxia-inducible factor 1
@en
Activation of vascular endothe ...... by hypoxia-inducible factor 1
@en-gb
Activation of vascular endothe ...... by hypoxia-inducible factor 1
@nl
prefLabel
Activation of vascular endothe ...... by hypoxia-inducible factor 1
@ast
Activation of vascular endothe ...... by hypoxia-inducible factor 1
@en
Activation of vascular endothe ...... by hypoxia-inducible factor 1
@en-gb
Activation of vascular endothe ...... by hypoxia-inducible factor 1
@nl
P2093
P2860
P921
P356
P1476
Activation of vascular endothe ...... by hypoxia-inducible factor 1
@en
P2093
P2860
P304
P356
10.1128/MCB.16.9.4604
P407
P577
1996-09-01T00:00:00Z